Venomous Caterpillar Genome Reveals How Antimicrobial Immune Peptides Evolved Into Pain-Causing Toxins

Researchers generated a near-chromosomal-level genome assembly for D. vulnerans. Gene loci encoding venom toxins were identified through genomic and transcriptomic analysis. Evolutionary relationships between venom peptides and cecropin immune peptides were established through phylogenetic analysis and positive selection testing. Functional characterization included bacterial and fungal growth inhibition assays (antimicrobial activity), mammalian neuronal membrane permeabilization assays (pain-related activity), and EC50 determination for key peptides.

This study provides a rare, clear example of how new biological functions evolve from existing ones — immune peptides becoming venom toxins through gene duplication and adaptive mutation. For peptide science, it reveals the structural features that determine whether a peptide kills bacteria or disrupts nerve cells, providing valuable design principles for both antimicrobial drug development (what makes cecropins effective?) and pain research (what makes peptides neurotoxic?). The 500-fold difference in neuronal potency between closely related peptides is a striking structure-activity relationship.

Venom peptides are among the most potent bioactive molecules in nature and have already yielded important drugs — the pain medication ziconotide came from cone snail venom, and exenatide (for diabetes) came from Gila monster venom. This study adds caterpillar venom to the peptide pharmacology toolkit and, more fundamentally, reveals how nature engineers peptide function. Understanding the mutations that convert an antimicrobial peptide into a neurotoxin could inform the design of next-generation antimicrobial peptides that avoid neurotoxicity, or conversely, help develop new analgesic or anesthetic compounds.

The functional characterization focused on three peptides (Dv11, Dv12, Dv13) from the 115 identified venom gene loci — the vast majority remain uncharacterized. The mammalian neuronal membrane assay measures permeabilization in vitro, which may not fully replicate the pain experience in intact organisms. The evolutionary pathway from immune peptide to toxin is inferred from sequence analysis and selection pressures, not directly observed. The study is in an insect (caterpillar) system, and the relevance of these specific peptides to human therapeutics requires further investigation.